BioSpace News Archive

Congenica and SFI Research Centre FutureNeuro Unite to Deliver More Accurate Diagnoses for Genetic Epilepsy

The alliance between Congenica and FutureNeuro, will further help the evolving understanding of the causes of many types of epilepsy and will also help to progress the exciting clinical alliance between genomics and electronic health records.

February 12, 2018

·

3 min read

Biotech Beach

Evolus Announces Closing of Initial Public Offering of Common Stock

Evolus raised approximately $60M in gross proceeds from the offering, before underwriting discounts and commissions and estimated offering expenses.

February 12, 2018

·

2 min read

Business

CRF Health Extends Product Strategy and Innovation Team With Industry Pioneer

CRF Health has today announced the appointment of Bill Byrom as Vice President of Product Strategy & Innovation.

February 12, 2018

·

2 min read

Policy

Intellipharmaceutics Meets with FDA Regarding Oxycodone ER NDA Development Program

Intellipharmaceutics today announced that it held a meeting with the United States FDA regarding the Company’s abuse-deterrent oxycodone hydrochloride extended release tablets product candidate.

February 12, 2018

·

7 min read

Drug Development

CBSET Release: Preclinical Safety Studies Must Include Equally Balanced Male/Female Animal Models to Shed Light on Sex-Dependent Vascular Responses in Humans

While the influence of sex on clinical outcomes is widely studied, many challenges remain.

February 12, 2018

·

3 min read

Drug Development

Intercept Announces Phase III REVERSE Trial Evaluating OCA for the Treatment of NASH Patients With Compensated Cirrhosis

REVERSE is a randomized, double-blind, placebo-controlled, multi-center study that will evaluate the efficacy and safety of the investigational therapy OCA in approximately 540 patients with a biopsy-confirmed diagnosis of cirrhosis due to NASH.

February 12, 2018

·

7 min read

Pharm Country

Inovio and The Wistar Institute Receive More Than $4.6M in R&D Funding to Advance Vaccines Against Tuberculosis & Malaria

The grants were from the Bill & Melinda Gates Foundation and the (NIH.

February 12, 2018

·

7 min read

FDA

Biotricity Update for Shareholders

The Company is on schedule to bring Bioflux to market within the next quarter and has already expanded its research and development efforts to capitalize on artificial intelligence AI.

February 12, 2018

·

5 min read

Pharm Country

Actinium Pharmaceuticals Reminds Investors of Today’s Deadline to be a Shareholder of Record

To be a shareholder of record, ownership of Actinium stock must occur by market close of February 12, 2018 to account for settlement.

February 12, 2018

·

8 min read

Business

Horizon Discovery Enters into License Agreement With U.S. Immuno-Oncology Company

Horizon has licensed to the Partner a novel cell line engineering technology as well as non-exclusive rights to Horizon’s proprietary Helitron transposon gene editing technology for an undisclosed financial consideration.

February 12, 2018

·

6 min read